2004 Annual Meeting | Therapy in Neurology

Date Monday 04/26/04

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Joseph R. Berger, MD, FAAN

Topic(s) General Neurology/Neurology of Systemic Disease

Learning Objectives Upon completion:
Participants should become familiar with the current treatments of a wide variety of neurological disorders and the mechanisms of these treatment options that render them effective.

The American Board of Psychiatry and Neurology has reviewed Therapy in Neurology and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		Stroke Jose Biller, MD, FACP, FAHA, FAAN
09:45 AM - 10:30 AM		Demyelinating Diseases John H. Noseworthy, MD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:30 AM		Neck, Back and Other Pains Robert Levy, MD, PhD
11:30 AM - 12:15 PM		Neurological Complications of AIDS Joseph R. Berger, MD, FAAN
12:15 PM - 01:30 PM		Lunch
01:30 PM - 02:15 PM		Movement Disorders C. W. Olanow, MD
02:15 PM - 03:00 PM		Neuromuscular Diseases Robert M. Pascuzzi, MD, FAAN
03:00 PM - 03:15 PM		Break
03:15 PM - 04:00 PM		Headache and Facial Pain Alan M. Rapoport, MD, FAAN
04:00 PM - 04:45 PM		Seizure Disorders Timothy A. Pedley, MD, FAAN
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dice Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Population Bio. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Berger has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Assorted .
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
John H. Noseworthy, MD, FAAN	No disclosure on file
C. W. Olanow, MD	Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Robert M. Pascuzzi, MD, FAAN	Dr. Pascuzzi has nothing to disclose.
Timothy A. Pedley, MD, FAAN	No disclosure on file
Alan M. Rapoport, MD, FAAN	Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews.
	No disclosure on file
Robert Levy, MD, PhD	No disclosure on file

��ɫ��

��ɫ��